RA
GH icon

Rise Advisors’s Guardant Health GH Stock Holding History

Rise Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-245
Closed -$15.3K – 633
2025
Q3 		$15.3K Hold
245
– – 0.01% 741
2025
Q2 		$12.8K Sell
245
-24
-9% -$1.07K 0.01% 846
2025
Q1 		$11.5K Buy
+269
New +$11.6K 0.01% 879

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rise Advisors's GH Position: Q4 2025 in Review

Rise Advisors sold out of Guardant Health (GH) in Q4 2025, closing a stake of 245 shares — an estimated $15.3K sold.

Rise Advisors first reported a position in GH in Q1 2025 and held it in 3 quarters. The position peaked at $15.3K in Q3 2025. 497 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • Rise Advisors reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 245 Guardant Health shares in Q4 2025, an estimated $15.3K.
  • Rise Advisors first reported a position in Guardant Health in Q1 2025 and held it in 3 quarters.
  • Rise Advisors's Guardant Health position peaked at $15.3K in Q3 2025.
  • 497 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.